Brief: Krystal Biotech Reports Q3 Loss Per Share Of $1.17
07/11/2022 12:47
Nov 7 (Reuters) - Krystal Biotech Inc KRYS.O :
* KRYSTAL BIOTECH ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* KRYSTAL BIOTECH INC - STRONG BALANCE SHEET, CLOSING
QUARTER WITH
$407.0 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS
* KRYSTAL BIOTECH INC QTRLY NET LOSS PER COMMON SHARE: BASIC
AND
DILUTED$1.17
Source text for Eikon: ID:nGNX11JSNn
Further company coverage: KRYS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Krystal Biotech
See all newsBrief: Krystal Biotech Announces Positive Clinical Data For New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression In Patients With Gorlin Syndrome
Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Krystal Biotech Q2 revenue rises on VYJUVEK strength
Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
Construction firm Tutor Perini jumps on S&P SmallCap inclusion